Renagade TX is a technology solutions provider that specializes in custom software development, IT consulting, and digital transformation services. The company prides itself on its innovative approach to solving complex business challenges through cutting-edge technology.

ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an all-RNA system for coding, editing and gene insertion to develop new medicines.

To accelerate the future of medicine, we bring together a team with deep RNA and delivery expertise to develop paradigm-shifting RNA medicines. 

ReNAgade Therapeutics – RNA Without Limits

F2 Ventures

MPM Capital

ReNAgade Therapeutics

At #JPM2024 next week, ReNAgade CEO Amit Munshi will present on the exciting updates we are making across our broad portfolio of novel RNA medicines. More details: https://bit.ly/48IpqJs

Our CEO, Amit Munshi, recently spoke with In Vivo reporter Melanie Senior, and told the publication that RNA medicines are among “the next set of modalities that will change what medicines look like.” Read the full story here: https://bit.ly/3RMqC8N

Welcome Paul Perreault to ReNAgade’s Board of Directors! With over 40 years of leadership experience across the biotechnology industry, Mr. Perreault will be invaluable as we continue to build our portfolio of novel RNA medicines. Read more: https://bit.ly/3t3Sz2u

Here is what the team at ReNAgade values about our cutting-edge science.

https://renagadetx.com/

#science #culture #biotech

RNA medicine and an inclusive culture are just a few of the reasons you should consider joining our team. Don't take our word for it, hear what Pooja and Johnny have to say about ReNAgade.

https://ow.ly/x3Tx50Q81MY

#careers #science #biotech

Dunk tanks, refreshing people, and all-team problem-solving are just a few of the reasons Reggie, Kimberly, and James are happy with the ReNAgade #experience.

https://renagadetx.com/

#biotech #experience #dunktank

We’re honored to have been nominated by The New England Venture Capital Association as Emerging Life Science Company of the Year at the #NEVYs23. We’re excited for the recognition and look forward to celebrating with the rest of the nominees!

Gain insights from Trevor, our Gene-Editing Co-op, as he shares about his experience at ReNAgade this semester. #intern #careers #biotech

At #mRNA2023, ReNAgade will present preclinical data demonstrating novel and proprietary lipid nanoparticle (LNP)-based delivery of mRNA to extra-hepatic tissue in a plenary session on 11/1 at 3:18PM CET (10:18AM ET). Full press release: https://bit.ly/3QByFVw

Taylor in Delivery Chemistry shared his favorite part about the #culture at ReNAgade…we’ll give you a hint: 🎶 🎸 🎙️

COM:RENAGADETX

Renagade TX

Analysis Not Available